Denali Therapeutics Inc.DNLI
Close of Friday, October 23, 2026 · Denali Therapeutics Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$18.41
vs its Pivot
-13.2%
OnlyAlpha Score
39
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -10.1% | +11.5% | +15.4% | -1.6% | -16.6% |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.22%IWM · 0.10%
Big investors that own it (latest 13F)
| Temasek | 0.5% of holdings |
| Baker Bros. Advisors | 0.5% of holdings |
Healthcare · Biotech
Get DNLI in your free daily emailAfter every close: whether DNLI is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track DNLI free → Full Stock check
Track DNLI free → Full Stock check